CHARLES RIVER LABORATORIES (CRL)
US1598641074 - Common Stock
| MRQ (2024-9-28) | 2023 (2023-12-30) | 2022 (2022-12-31) | 2021 (2021-12-25) | 2020 (2020-12-26) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 210.17M | 276.77M | 233.91M | 241.21M | 228.40M | |||
| Marketable Securities | 69.00K | 68.00K | 998.00K | 1.06M | 1.00M | |||
| Receivables | 754.21M | 780.38M | 752.39M | 650.38M | 617.70M | |||
| Inventories | 336.20M | 380.26M | 255.81M | 199.15M | 185.70M | |||
| Other Current Assets | 194.08M | 171.19M | 195.92M | 182.29M | 168.30M | |||
| Total Current Assets | 1.49B | 1.61B | 1.44B | 1.27B | 1.20B | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.03B | 2.03B | 1.86B | 1.58B | 1.30B | |||
| Investments And Advances | 235.99M | 243.81M | 311.60M | 201.35M | 221.80M | |||
| Goodwill | 3.12B | 3.10B | 2.85B | 2.71B | 1.81B | |||
| Intangibles | 778.46M | 864.05M | 955.27M | 1.06B | 787.60M | |||
| Other Non-Current Assets | 344.97M | 349.66M | 189.54M | 191.76M | 168.60M | |||
| Total Non-Current Assets | 6.51B | 6.59B | 6.16B | 5.75B | 4.29B | |||
| TOTAL ASSETS | 8.00B | 8.20B | 7.60B | 7.02B | 5.49B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.20M | 5.57M | 3.68M | 2.79M | 50.20M | |||
| Accrued Expenses | 419.20M | 496.02M | 463.36M | 508.18M | 381.30M | |||
| Accounts Payable | 135.96M | 168.94M | 205.91M | 198.13M | 122.50M | |||
| Other Current Liabilities | 453.86M | 384.55M | 418.63M | 324.08M | 285.70M | |||
| Total Current Liabilities | 1.01B | 1.06B | 1.09B | 1.03B | 839.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.33B | 2.65B | 2.71B | 2.66B | 1.93B | |||
| Deferred Taxes/Income | 167.75M | 191.35M | 215.58M | 239.72M | 217.00M | |||
| Other Non-Current Liabilities | 669.50M | 642.42M | 564.57M | 495.83M | 360.80M | |||
| Total Non-Current Liabilities | 3.21B | 3.54B | 3.53B | 3.46B | 2.54B | |||
| TOTAL LIABILITIES | 4.22B | 4.60B | 4.63B | 4.49B | 3.38B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 2.12B | 1.89B | 1.43B | 980.75M | 625.40M | |||
| Additional Paid In Capital | 1.97B | 1.91B | 1.80B | 1.72B | 1.63B | |||
| Minority Interest | 45.44M | 62.12M | 47.21M | 57.17M | 29.10M | |||
| Common Shares | 517.00K | 513.00K | 509.00K | 505.00K | 500.00K | |||
| Treasury Stock | -119.62M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -192.87M | -196.43M | -262.06M | -164.74M | -138.90M | |||
| Shares Outstanding | 51.13M | 51.34M | 50.94M | 50.48M | 49.80M | |||
| Tangible Book Value per Share | -2.36 | -7.06 | -16.27 | -24.53 | -9.68 | |||
| Total Shareholders' Equity | 3.78B | 3.60B | 2.98B | 2.53B | 2.11B | |||
| TOTAL LIABILITIES AND EQUITY | 8.00B | 8.20B | 7.60B | 7.02B | 5.49B | |||
| Statistics | ||||||||
| Debt/Equity | 0.62 | 0.74 | 0.91 | 1.05 | 0.91 | |||
| Current Ratio | 1.48 | 1.52 | 1.32 | 1.23 | 1.43 | |||
| Return On Assets (ROA) | 5.16% | 5.79% | 6.40% | 5.57% | 6.63% | |||
| Return On Equity (ROE) | 10.92% | 13.20% | 16.34% | 15.42% | 17.23% | |||
| Return On Invested Capital (ROIC) | 7.07% | 7.47% | 8.19% | 8.54% | 7.89% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.28% | 7.77% | 8.50% | 8.90% | 8.30% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 17.16% | 18.36% | 21.59% | 25.90% | 20.12% | |||
All data in USD , ROIC based on taxRate of 0.19